chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Hypoaesthesia, Joint range of motion decreased, Oedema peripheral
Clinical narrative: There was erythema and swollen from wrist to shoulder. Numbness and low range of motion.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chills, Headache, Nausea, Vomiting
Clinical narrative: Pt states next day after Influenza vac administration on 10/4/10; developed nausea, vomiting, severe weakness, headache, chills, sx lasted for 3-4d.
Age: 19.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Malaise
Clinical narrative: Site of injection w/erythema, warmth, swelling, pain. The patient developed fevers and malaise x 48hrs. at site of PNEUMOVAX.
Age: 19.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Pyrexia
Clinical narrative: Site of injection w/erythema, warmth, swelling, pain. The patient developed fevers and malaise x 48hrs. at site of PNEUMOVAX.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test, Chest discomfort, Chest pain, Dyspnoea, Electrocardiogram
Clinical narrative: Shortness of breath, pain in neck, tingling in fingers/toes, chest pain, heaviness in chest.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain, Paraesthesia
Clinical narrative: Shortness of breath, pain in neck, tingling in fingers/toes, chest pain, heaviness in chest.
Age: 2.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Body temperature increased, Injection site erythema, Injection site pain, Injection site swelling, Laboratory test normal
Clinical narrative: Patient had T 101.9 and leg pain hours after vaccination. Received PCV 13 right thigh and Flu left thigh. Next day had right knee swelling + redness and was admitted to hospital. W/U - neg
Age: 42.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Joint crepitation, Pain in extremity
Clinical narrative: Sore left arm on 10/1/10 pt saw PMD for sore arm and was given DARVOCET for pain. 10/8/10 TC from patient stating continued left arm pain an it "pops" when she lifts it up.
Age: 30.0
Sex: M
Vaccine: FLU3
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: On 10/19/10 day after Flu vaccine, patient broke out in hives on legs, arms, chest & back, treated with CLARITIN and BENADRYL. Grade 2 allergic reaction.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Pharyngeal oedema, Throat irritation
Clinical narrative: Student (patient) complained of "scratchy" and slightly swollen throat 5 minutes after flu shot given. Some cough with no wheezing - given. BENADRYL 25 mg by mouth and epinephrine auto injector 0.3mg. Temperature 98.6 degrees F and oxygen saturation 100%.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Asthenia, Dyspnoea, Headache, Hypoaesthesia
Clinical narrative: Approx 7cm swelling at inj. site - improving fever of 100 degrees thru 10/23/ decreased energy - improving seizure-like tremor whole L. side - resolved numb fingers (all) - resolved/generalized arthralgia - resolved/major S.O.B - resolved/HA -improving.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site swelling, Pyrexia, Tremor
Clinical narrative: Approx 7cm swelling at inj. site - improving fever of 100 degrees thru 10/23/ decreased energy - improving seizure-like tremor whole L. side - resolved numb fingers (all) - resolved/generalized arthralgia - resolved/major S.O.B - resolved/HA -improving.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Vomiting
Clinical narrative: Vomiting & fever 1 hr after administration & on into next day.
Age: 0.61
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased
Clinical narrative: Duration is 1 Day(s). Maximum temperature is 102.5 F. The frequency of the symptom is intermittent. Context includes concurrent URI symptoms and sick contacts at home. Associated symptoms include nasal drainage. Pertinent negatives include cough, diarrhea, rash or vomiting. Additional information: Two days ago, patient received influenza vaccination.
Age: 14.0
Sex: F
Vaccine: FLU3, HEPA, HPV4, VARCEL
Symptoms: Gaze palsy, Loss of consciousness, Musculoskeletal stiffness, Tremor
Clinical narrative: Patient passed with final vaccination, I observed the patient's eyes roll back into head. Arms/hands clenched to chest with tremors all over body.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Chest pain, Dyspnoea, Fatigue, Haematochezia, Hypersomnia
Clinical narrative: Heart was racing became very tired, hard to breathe. Blood in stool. Rash on face left cheek, chin. Sore throat, slept a lot, chest pain.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Oropharyngeal pain, Palpitations, Rash
Clinical narrative: Heart was racing became very tired, hard to breathe. Blood in stool. Rash on face left cheek, chin. Sore throat, slept a lot, chest pain.
Age: 50.0
Sex: U
Vaccine: FLU3, PPV, TDAP
Symptoms: Headache, Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever of 102, rash, headache, nausea, body ache, tenderness and pain on right arm.
Age: 50.0
Sex: U
Vaccine: FLU3, PPV, TDAP
Symptoms: Rash, Tenderness
Clinical narrative: Fever of 102, rash, headache, nausea, body ache, tenderness and pain on right arm.
Age: 83.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site streaking
Clinical narrative: Red streaks around injection site.
Age: 43.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Chills, Malaise, Pain, Pyrexia
Clinical narrative: Pt. received TDAP and AFLURIA Flu-vaccines on 10/22/10. Pt reported fever, chills, body aches, malaise later that evening.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Patient developed severe swelling surrounding injection site & pain. Gave patient water & diphenhydramine made patient stay in pharmacy additional 15 mins. Patient stated no further swelling. Called patient several hours later & she said she was fine.
Age: 35.0
Sex: M
Vaccine: FLU3
Symptoms: Convulsion, Loss of consciousness
Clinical narrative: Pt received flu shot, a couple of minutes later pt passed out and started seizing. After a couple of minutes pt was feeling ok. I called paramedics but they did not take him to the hospital.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Musculoskeletal pain, Pain, Pain in extremity
Clinical narrative: Received Flu shot on Friday Sept. 17, 2010 - shot a little low at 5 fingers from (3AT) shoulder and a little lateral. No pain at time of the shot but next morning had pain in shoulder blades down to fingers. Got worse & worse. By Sunday AM went to Urgent Care & sent home with prescription for Ibuprofen. Iced/heating pad. Monday PM went to PCP & put on LYRICA and pain meds. Pain continues went back to PCP on Friday & has appt. for "Accelerated " pain center recovery specialist appt. on Thursday.
Age: 1.67
Sex: M
Vaccine: FLU3, HEPA, MMR, VARCEL
Symptoms: Full blood count, Platelet count decreased, Thrombocytopenic purpura
Clinical narrative: Thrombocytopenic Purpura
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, Chest discomfort, Chest pain, Headache
Clinical narrative: (1) Headache ("Dull") back of upper head (2) Chest tightness (burning) (3) Pain ("Dull") (R) Lower back-since 1030A today. Client took TYLENOL (500 mg) at 945 am today.
Age: 10.0
Sex: M
Vaccine: FLU3, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Mild swelling and redness on right deltoid.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea & vomiting 3 days after receiving flu shot. Ptnt states occurring for 24 hrs.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Blood pressure increased, Palpitations, Respiratory distress
Clinical narrative: Exactly 4 hrs after shot, patient had heart palpitations, respiratory distress and elevated blood pressure. Was treated at ER with IV prednisone, BENADRYL & PEPCID.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site reaction, Myalgia, Pain in extremity
Clinical narrative: Pt received influenza vaccine on 9/29/2010 in the left upper arm. Pt returned to pharmacy on 10/24/10 complaining he hadn't been able to move his left arm since he received the vaccine and that it is very sore. He said there was no visible marking only muscle soreness. He also said he contacted his Dr & was told to return to pharmacy.
Age: 48.0
Sex: M
Vaccine: FLU3
Symptoms: Blood test, Computerised tomogram, Hypoaesthesia, Lumbar puncture, Nuclear magnetic resonance imaging
Clinical narrative: Received Flu shot and the next day had numbness in hands that went to fingers and progressed over the next week to the arm chest face and head. Went to ER and they did CT Scan, Spinal tap, X Ray bloodwork. Was in hospital for 3 days. Has not had Flu shot since 2003 - did not have H1N1. Now has tremors in hands- possible diagnosis MS.
Age: 48.0
Sex: M
Vaccine: FLU3
Symptoms: Tremor, X-ray
Clinical narrative: Received Flu shot and the next day had numbness in hands that went to fingers and progressed over the next week to the arm chest face and head. Went to ER and they did CT Scan, Spinal tap, X Ray bloodwork. Was in hospital for 3 days. Has not had Flu shot since 2003 - did not have H1N1. Now has tremors in hands- possible diagnosis MS.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Dizziness, Headache, Pyrexia
Clinical narrative: Dizziness, upset stomach, headache, high temp.
Age: 23.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Dizziness, Feeling hot, Headache
Clinical narrative: Headache/lightheaded, weak, face was feeling hot, dizzy. 1st ever flu vaccine.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Feeling hot, Headache, Increased upper airway secretion, Pain
Clinical narrative: Had to stay in bed - fatigue required bed rest x 2 days. Aches all over. Felt feverish - didn't check temperature. Headache. Small increase in nasal secretions. Takes EXCEDRIN regularly for arthritis. No extra taken.
Age: 90.0
Sex: U
Vaccine: TD
Symptoms: Hypersensitivity, Injection site rash
Clinical narrative: Pt. was seen on 10-23-10 for laceration repair and needed a TD shot. On 10-25-10 pt. came in c/o red rash on arm where TD was given.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Dry skin, Immunisation reaction, Injection site discolouration, Injection site dryness, Injection site erythema
Clinical narrative: Day after vaccine given; developed erythema of thighs & swelling rash on arms & legs by next day. Arms & legs were swollen & puffy skin whitish. Went to U/C given hydrocortisone to apply dx with immunization reaction (thighs) 10-25 skin peeling like sunburn now. Skin arms & legs very dry. Had brief episode lasted seconds mom thought she heard a wheeze - gasp then was fine 10/22 pm.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Injection site rash, Injection site swelling, Rash, Skin discolouration, Skin exfoliation
Clinical narrative: Day after vaccine given; developed erythema of thighs & swelling rash on arms & legs by next day. Arms & legs were swollen & puffy skin whitish. Went to U/C given hydrocortisone to apply dx with immunization reaction (thighs) 10-25 skin peeling like sunburn now. Skin arms & legs very dry. Had brief episode lasted seconds mom thought she heard a wheeze - gasp then was fine 10/22 pm.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Wheezing
Clinical narrative: Day after vaccine given; developed erythema of thighs & swelling rash on arms & legs by next day. Arms & legs were swollen & puffy skin whitish. Went to U/C given hydrocortisone to apply dx with immunization reaction (thighs) 10-25 skin peeling like sunburn now. Skin arms & legs very dry. Had brief episode lasted seconds mom thought she heard a wheeze - gasp then was fine 10/22 pm.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site swelling, Oedema peripheral
Clinical narrative: Patient presented to the office 10/25/10 for PPD reading - also c/o swelling (R) shoulder at the site of KINRIX injection also swelling upper arm - non tender treatment: BENADRYL 1 Tsp PO QID x 1 wk.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Injection site haemorrhage, Injection site induration, Irritability
Clinical narrative: 4 hours after vaccination IM (L) thigh -> 4 cm induration with petechiae formation. Treated with ten mg/kg acetaminophen resolved induration and irritability at 24 hours.
Age: 51.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Cellulitis, Oedema peripheral, Tenderness
Clinical narrative: Swelling & tenderness noted in (R) arm. Pt saw her MD and was diagnosed with cellulitis & treated with antibiotics: Sulfamethoxazole-trimethoprim.
Age: 27.0
Sex: F
Vaccine: FLUN3
Symptoms: Diagnostic procedure, Erythema, Hypersensitivity, Urticaria
Clinical narrative: 10/25 - Developed red whelps on right arm, left leg, & trunk. Examined by CRNP, negative Woods lamp test. Dx. - systemic allergic rxn.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Fall, Gaze palsy, Loss of consciousness, Tremor
Clinical narrative: Patient passed out, fell, observed eyes rolling to back of head, patients arms were clenching, tremors observed throughout entire body. Episode lasted about 20-30 seconds.
Age: 73.0
Sex: M
Vaccine: PPV
Symptoms: Injection site mass
Clinical narrative: Pt reports a "golf ball" size knot at the injection site the night of receiving his pneumonia vaccine.
Age: 62.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Musculoskeletal pain, Pain in extremity
Clinical narrative: Patients states that she began having right arm pain - 3 to 4 hours after receiving the vaccine on 10/6/10. Complains of right shoulder, arm & elbow pain. States pain was severe for the 1st 3 days - has improved some but still has pain. Patient taking TYLENOL, tried applying heat & ice with mild relief.
Age: 41.0
Sex: U
Vaccine: FLU3
Symptoms: Erythema, Pain, Pruritus, Swelling
Clinical narrative: Grapefruit size red, swollen, painful itchy spot.
Age: 48.0
Sex: F
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 35.0
Sex: F
Vaccine: TYP, YF
Symptoms: Asthenia, Cough, Malaise, Nasopharyngitis, Pyrexia
Clinical narrative: T/C 10/5 - c/o of fever 101+, myalgia, weakness day after vaccines; cold symptoms (rhinorrhea, cough) started day 2 after vaccines; Day 3 cold symptoms increased with head pressure also Day 4 c/o cont. head pressure, weakness, fever & cold sx. 10/20 symptoms lasted 7-10 days none now/TC today.
Age: 35.0
Sex: F
Vaccine: TYP, YF
Symptoms: Rhinorrhoea
Clinical narrative: T/C 10/5 - c/o of fever 101+, myalgia, weakness day after vaccines; cold symptoms (rhinorrhea, cough) started day 2 after vaccines; Day 3 cold symptoms increased with head pressure also Day 4 c/o cont. head pressure, weakness, fever & cold sx. 10/20 symptoms lasted 7-10 days none now/TC today.
Age: 52.0
Sex: F
Vaccine: TD
Symptoms: Erythema, Skin warm
Clinical narrative: Redness, warm to touch.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Vaccine given IM in (L) UE. (L) arm became very swollen, warm to touch, painful. She went to the doctor. The doctor gave her steroids (prednisone). Monday morning arm is without swelling & redness.
Age: 78.0
Sex: M
Vaccine: FLU3
Symptoms: Encephalopathy, Full blood count, Pancytopenia, Platelet count normal, Pyrexia
Clinical narrative: 7 hours after vaccination pt developed fever to 103 and encephalopathy along with pancytopenia. Was hospitalized and cleared after 24 hours.
Age: 78.0
Sex: M
Vaccine: FLU3
Symptoms: Red blood cell count normal, White blood cell count decreased
Clinical narrative: 7 hours after vaccination pt developed fever to 103 and encephalopathy along with pancytopenia. Was hospitalized and cleared after 24 hours.
Age: 81.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Erythema, Injection site erythema, Injection site warmth, Neutrophil percentage
Clinical narrative: Arm near injection turned red and hot. Redness spread down to elbow. Redness continued x 48 hours. Redness just at injection site at discharge. IV push diphenhydramine given with no relief.
Age: 81.0
Sex: F
Vaccine: PPV
Symptoms: Skin warm, White blood cell count normal
Clinical narrative: Arm near injection turned red and hot. Redness spread down to elbow. Redness continued x 48 hours. Redness just at injection site at discharge. IV push diphenhydramine given with no relief.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Blood creatine phosphokinase MB, Cardiac enzymes normal, Dizziness, Dyspnoea, Electrocardiogram normal
Clinical narrative: Acute reaction a few minutes after FLULAVAL was administered. Patient experienced diaphoresis, shortness of breath, flushing, dizziness, and feeling as if she was going to pass out. Monitored for 2 hours. BP, HR, O2 sat, cardiac enzymes, EKG all stayed stable. Slowly improved with O2 and Sl. Nitro. No rash/hives. Monitored for 2 more hours, stable and tired condition.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Flushing, Hyperhidrosis, Troponin
Clinical narrative: Acute reaction a few minutes after FLULAVAL was administered. Patient experienced diaphoresis, shortness of breath, flushing, dizziness, and feeling as if she was going to pass out. Monitored for 2 hours. BP, HR, O2 sat, cardiac enzymes, EKG all stayed stable. Slowly improved with O2 and Sl. Nitro. No rash/hives. Monitored for 2 more hours, stable and tired condition.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Myopericarditis
Clinical narrative: Initial report received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381705.  A 21-year-old male patient received a dose of ACAM2000 vaccine, live (lot number VV04003A) on 11 February 2010.  Ten days post-inoculation on 21 February 2010, the patient developed myopericarditis with chest pain and effusion.  On the same day, his Troponin level was increased and he had an abnormal echocardiogram.  The events required prolonged hospitalization.  The patient's medical history was not reported.  Recovery status was not reported.  Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Echocardiogram abnormal, Effusion, Myopericarditis, Troponin increased
Clinical narrative: Initial report received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381705.  A 21-year-old male patient received a dose of ACAM2000 vaccine, live (lot number VV04003A) on 11 February 2010.  Ten days post-inoculation on 21 February 2010, the patient developed myopericarditis with chest pain and effusion.  On the same day, his Troponin level was increased and he had an abnormal echocardiogram.  The events required prolonged hospitalization.  The patient's medical history was not reported.  Recovery status was not reported.  Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Herpes zoster
Clinical narrative: Initial report was received via a Q-Scan search of the VAERS database on 30 July 2010 under the reference number 381732. A 22-year-old male patient received ACAM2000 (lot number VV04-003-A) on 13 February 2010. Six days after receiving the ACAM200, the patient had an outbreak of herpes zoster. The patient recovered. Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Pericarditis
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: C-reactive protein increased, Cellulitis, Chest discomfort, Chest pain, Chills
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dizziness, Dyspnoea, Electrocardiogram ST segment elevation, Electrocardiogram normal, Fatigue
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: High density lipoprotein increased, Hyperlipidaemia, Injection site erythema, Injection site necrosis, Injection site oedema
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site pain, Leukocytosis, Low density lipoprotein increased, Musculoskeletal pain, Myalgia
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Neck pain, Neutrophil percentage increased, Pain, Painful respiration, Pericardial rub
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pericarditis, Pyrexia, Sinus tachycardia, White blood cell count increased
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381899. A 34 year-old male patient received ACAM2000 (lot number W04-003) on 18 February 2010. On 28 February 2010, 10 days post-vaccination, the patient experienced mild fatigue. The following day he developed chest tightness and difficulty breathing. Symptoms did not resolve, and so the patient presented to his physician and was admitted to the hospital. The patient was diagnosed with pericarditis, with additional symptoms of cellulitis, dizziness, injection site erythema, musculoskeletal pain, painful respirations, injection site necrosis, myalgia, chest pain, injection site pain, chills pain, pyrexia, chest discomfort, injection site oedema, and neck pain. Testing revealed in increased C-reactive protein, increased white blood count, increased neutrophil percentage, and leukocytosis. Hyperlipidemia was also noted, with increased low and high density lipoprotein. An electrocardiogram was normal, with ST segment elevation, sinus tachycardia, and pericardial rub. Additional information, including treatment and outcome, was not reported.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Chest discomfort, Computerised tomogram normal, Dyspnoea, Echocardiogram abnormal
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Ejection fraction decreased, Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Myoglobin blood increased, Nuclear magnetic resonance imaging normal
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Troponin I increased
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB, Chest X-ray normal, Chest discomfort, Chest pain, Coronary artery insufficiency
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram ST segment elevation, Laboratory test abnormal
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Mitral valve incompetence, Myocarditis, Myoglobin blood increased, Painful respiration, Pleuritic pain
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Poor quality sleep, Tricuspid valve incompetence, Troponin increased
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381904.  A 20 year-old male patient received ACAM2000 (lot number W04003A) on 07 August 2009.  Ten days post vaccination, on 17 August 2009, the patient complained of chest tightness.  Symptoms progressed to "constant pains across his anterior chest", that worsened with lying down, walking, and deep breathing, described as 5-6 out of 10.  He also had mild shortness of breath.  Pain continued to worsen, and the patient was seen in the emergency room where he was noted to have ST elevations inferiorly and laterally.  Troponin was 1.95.  The patient was transferred to another facility, and was treated with LOVENOX and LOPRESSOR.  His blood pressure remained 100/70 after 4 liters of fluid.  An EKG demonstrated ST elevations, and an ECHO showed depressed ejection fraction of 40-50% with global WMA (wall motion abnormality), mild to moderate MR (mitral regurgitation), mild TR (tricuspid regurgitation), and mild AI (atrial insufficiency).  A chest x-ray was negative for PE (pulmonary embolism) and pericarditis.  Troponin I was 1.9, and later peaked at 8.9; CK-MB was 10.8; and Myoglobin was 110.  Additional symptoms included poor quality sleep and pleuritic pain; the patient was diagnosed with myocarditis.  He subsequently recovered on an unspecified date.
Age: 37.0
Sex: M
Vaccine: ANTH, FLUN(H1N1), HEP, SMALL, ANTH, FLUN3, HEP, SMALL
Symptoms: Folliculitis, Generalised vaccinia, Herpes zoster, Rash, Viral infection
Clinical narrative: Initial report received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381949. A 37 year-old male patient received on 17 February 2010 the following vaccinations: a dose of ACAM2000 (lot number VV04004); a second intramuscular injection of BIOTHRAX (manufacturer Emergent Biosolutions (lot number FAV204); A first intranasal dose of Medimmune H1N1 vaccine (manufacturer Medimmune vaccine, Inc., lot number 500822P); and a second intramuscular injection of ENGERIX B (manufacturer GlaxoSmithKline, lot number AHBVB697BA). On the same day at an unspecified time, the patient complained of rash that started on the forearms, the post head in the scalp and then on the buttocks. He developed post-vaccinial non-viral pustulosis, generalized vaccinia, folliculitis, herpes zoster varicella, or secondary infection. The event required emergency room or doctor visit (ER). Treatments received were not reported. The patient's medical history and recovery status was also not reported. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: ANTH, FLUN(H1N1), HEP, SMALL, ANTH, FLUN3, HEP, SMALL
Symptoms: Folliculitis, Generalised vaccinia, Herpes zoster, Infection, Rash
Clinical narrative: Initial report received on 30 July 2010 via a QScan search on the VAERS database, under reference number 381949. A 37 year-old male patient received on 17 February 2010 the following vaccinations: a dose of ACAM2000 (lot number VV04004); a second intramuscular injection of BIOTHRAX (manufacturer Emergent Biosolutions (lot number FAV204); A first intranasal dose of Medimmune H1N1 vaccine (manufacturer Medimmune vaccine, Inc., lot number 500822P); and a second intramuscular injection of ENGERIX B (manufacturer GlaxoSmithKline, lot number AHBVB697BA). On the same day at an unspecified time, the patient complained of rash that started on the forearms, the post head in the scalp and then on the buttocks. He developed post-vaccinial non-viral pustulosis, generalized vaccinia, folliculitis, herpes zoster varicella, or secondary infection. The event required emergency room or doctor visit (ER). Treatments received were not reported. The patient's medical history and recovery status was also not reported. Documents held by sender: None.
Age: 40.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Iritis, Lymphadenopathy
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382015. A 40 year-old male patient received the following vaccinations on 13 July 2009: ACAM2000, lot not reported), and anthrax vaccine (manufacturer and lot not reported). (NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.) The day of vaccination, the patient developed femoral adenopathy and iritis. No additional information was provided, and outcome was unknown.
Age: 34.0
Sex: F
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Cellulitis, Urticaria
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382077. A 34 year-old female patient received the following vaccinations on 07 February 2010: ACAM2000 (VV04-003-A), and intramuscular H1N1 (Novartis, lot number 104044P1). (NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.) On 14 February 2010, 7 days post-vaccination, the patient developed cellulitis with hives requiring an emergency room visit. The patient recovered, events resolved; stop date was not reported.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Post vaccination autoinoculation
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number (VAERS ID 382103).  A 19-year-old male patient received the following vaccination in the left deltoid on 26 February 2010: ACAM2000 (lot number VV04-0033).  Seven days later on 05 March 2010, a small outbreak (also reported as post-vaccination autoinoculation) had spread to the left AC space.  Both sites had been bandaged and the patient was educated.  The event required an emergency room or doctor's visit.  The patient's recovery status was not reported.  Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Feeling abnormal, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382104.  An 18-year-old male patient received ACAM2000 (lot number VV04-003A) on 26 February 2010.  He later developed swelling, heat, and redness to the upper left arm which "feels like a pulled muscle".  He was seen in the emergency room; no additional information was reported.
Age: 18.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Myalgia, Oedema peripheral, Skin warm
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382104.  An 18-year-old male patient received ACAM2000 (lot number VV04-003A) on 26 February 2010.  He later developed swelling, heat, and redness to the upper left arm which "feels like a pulled muscle".  He was seen in the emergency room; no additional information was reported.
Age: 36.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blister, Erythema, Feeling abnormal, Myalgia, Pruritus
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382130.  A 36-year-old male patient received ACAM2000 (lot number VV04-003A) on 25 February 2010.  Eight days post-vaccination, he developed a rash with localized redness, bump, whitish blister, scab, and local itching.  He also complained of muscle aches and "feeling lousy".  He was treated with Septra; outcome was not reported.  Documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Rash, Rash papular, Scab
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382130.  A 36-year-old male patient received ACAM2000 (lot number VV04-003A) on 25 February 2010.  Eight days post-vaccination, he developed a rash with localized redness, bump, whitish blister, scab, and local itching.  He also complained of muscle aches and "feeling lousy".  He was treated with Septra; outcome was not reported.  Documents held by sender: none.
Age: 36.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Rash, Scab
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382130.  A 36-year-old male patient received ACAM2000 (lot number VV04-003A) on 25 February 2010.  Eight days post-vaccination, he developed a rash with localized redness, bump, whitish blister, scab, and local itching.  He also complained of muscle aches and "feeling lousy".  He was treated with Septra; outcome was not reported.  Documents held by sender: none.
Age: 32.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Dyspnoea, Left ventricular hypertrophy, Troponin I increased
Clinical narrative: Initial report was received via a Q-Scan search of the VAERS database on 30 July 2010. The VAERS case ID number was reported as 382347. A 32-year-old male patient had received a first dose percutaneous injection of ACAM2000, lot number VV04003A on 23 February 2010, and eight days later (also reported as 03 March 2010), he experienced chest pain with shortness of breath, left ventricular hypertrophy and High - Troponin I Cardiac (results not reported). The event required hospitalization and the patient recovered (dates not reported). Documents held by sender: None.
Age: 27.0
Sex: M
Vaccine: ANTH, HEP, HEPA, SMALL, ANTH, HEP, HEPA, SMALL
Symptoms: Joint swelling, Rash erythematous
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 382637.  A 27-year-old male patient received the following vaccines on 23 February 2010: ACAM2000 (lot number VV04-003A); ANTHRAX vaccine (lot number FAV218); HEP A vaccine (manufacturer and lot number not reported); and HEP B vaccine (manufacturer and lot number not reported).  One day post-vaccination, he developed red bumps on his body, including the face, neck, arms, legs, chest, and abdomen, and swelling of both ankles.  He was seen in the emergency room.  Outcome was not reported.